KAKEN PHARMACEUTICAL CO., LTD. · 科研製薬株式会社
Last · Tokyo¥3810.00+25.00 (+0.66%)close · yahoo · 13h ago
Market cap¥144.3B37.9M sh
P/E · TTM67.8fwd 39.5 · eps 56.18
Beta—vs S&P 500
Div yield5.00%annual · TTM
52w range
¥3540.00¥4445.00
Volume27.6Ksession
| Revenue | ¥76.9B |
|---|---|
| Operating income | ¥-899.0M |
| Net income | ¥2.1B |
| Free cash flow | ¥-14.8B |
| Operating margin | -1.2% |
| Net margin | 2.8% |
| Return on equity | 1.6% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-06-25
- Operating Cf Burn
Red flags
- Operating Cf Burn — Negative operating cash flow
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Documents
FormReporting forFiledFlags